GlassScriptPhysician profile
Michael S Cross
NPI 1689105256
$8,722.30
in general payments reported to CMS, 2019-2025
19 companies · $2,407 in 2025
The $2,407 reported for 2025 was more than what 86% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $394 · 2022: $918 · 2023: $1,929 · 2024: $3,074 · 2025: $2,407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,420 · Travel and Lodging: $1,605 · Education: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,419.56 |
| Travel and Lodging | $1,605.10 |
| Education | $385.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $2,914.27 | 2021-2025 | Impella |
| Shockwave Medical, INC | $1,426.49 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $1,417.79 | 2021-2025 | Cardiomems, Dragonfly Opstar, Mitraclip |
| Medtronic, INC. | $980.68 | 2022-2025 | Onyx Frontier, Corevalve Evolut R, Telescope |
| Philips North America LLC | $521.10 | 2024-2025 | (Bh4) Igt Devices Undivided, Ecc Solutions |
| Boston Scientific Corporation | $415.06 | 2021-2025 | General - Therapies, General - Balloon Catheters |
| Angiodynamics, INC. | $313.78 | 2025 | Alphavac, Angiovac |
| W. L. Gore & Associates, INC. | $249.08 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Viabahn Endoprosthesis With Heparin |
| Biotronik INC. | $158.11 | 2022-2023 | Nhancer Rx, Recross |
| Edwards Lifesciences Corporation | $128.84 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Lantheus Medical Imaging, INC. | $29.26 | 2024 | |
| Asahi Intecc USA, INC. | $28.13 | 2021-2024 | Peripheral Vascular |
| Tersera Therapeutics LLC | $27.49 | 2023 | Zoladex |
| Heartflow, INC. | $24.53 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $19.39 | 2023 | Lifevest |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aveo Pharmaceuticals, INC. | $19.33 | 2024 | |
| Cardiva Medical, INC. | $17.48 | 2025 | Cardiva Vascade 6/7f Vcs |
| Novartis Pharmaceuticals Corporation | $16.04 | 2025 | |
| Stemline Therapeutics INC. | $15.45 | 2025 | Orserdu |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Cross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.